Has Swetaben Patidar, MD received payments from drug or device companies?

Yes. Drug and device makers reported $2,491 in general payments to Swetaben Patidar, MD across 45 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Swetaben Patidar, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Swetaben Patidar, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Swetaben Patidar, MD

Internal Medicine · St Petersburg, FLNPI 1144750258

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 45 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 12 manufacturers reported payments, led by AstraZeneca at 24.6% of the total. Reporting peaked in 2021 at $762 and has fallen 54.5% since, to $346 in 2025.

$2,491in general payments, 2019–2025

Across 45 payments — averaging $55.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AstraZeneca$613
Novo Nordisk$389
Abbott$266
Amgen$244
Esperion Therapeutics, Inc.$225
Lilly USA, LLC$197
plus $558 from 6 others

What the payments were for

Food & beverage$2,491100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AstraZeneca	6	$613
Novo Nordisk	10	$389
Abbott	7	$266
Amgen	3	$244
Esperion Therapeutics, Inc.	2	$225
Lilly USA, LLC	5	$197
AbbVie	7	$174
Biohaven Pharmaceutical Holding Company Ltd.	1	$125
Dexcom, Inc.	1	$109
Boehringer Ingelheim	1	$101
Bayer	1	$27
Exact Sciences	1	$22

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,491 in reported general payments places this provider in the 80th percentile of 8,530 internal medicine providers in Florida.

See all internal medicine providers in Florida →

Medicare billing

Part B allowed, 2024

$163,698

Medicare patients

343

Services billed

1,454

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
EliquisApixaban	18	$11,808
Cefdinir	29	$363
Amlodipine Besylate	19	$279
Atorvastatin Calcium	35	$242
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav	15	$220
Metoprolol Succinate	17	$182
Losartan Potassium	19	$175
Pantoprazole Sodium	20	$149
Fluticasone Propionate	14	$138
Levothyroxine Sodium	15	$131
Tamsulosin Hcl	11	$131
Potassium Chloride	15	$125
Lisinopril	19	$107
Doxycycline Hyclate	11	$86
Prednisone	24	$73

Paid to pharmacies, not to this prescriber.

Other internal medicine in St Petersburg

Donald ThomasSt Petersburg$100K
Haytham ElgammalMiami$2.2M
Keith RubinFort Lauderdale$2M
Michael SensionFort Lauderdale$1M
Quang NguyenOcala$434K
Luis Correa LunaSanford$412K
Michael OleksykFort Myers$365K
Andrew KuykendallTampa$322K
Howard FederoffCoconut Grove$302K
Bianka EperjesiovaGainesville$260K

See the full list for Florida →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →